x

Coronavirus

EMA Has Granted Its First Approval for a Drug to Treat COVID-19

LONDON — The European Medicines Agency has granted its first approval for a drug to treat the new coronavirus — remdesivir, which has been shown in trials to speed the recovery time of people hospitalized with COVID-19.

The regulatory agency says it was granting a conditional marketing authorization for remdesivir to be used in treating adults and adolescents older than 12 with pneumonia who require oxygen.

“Remdesivir is the first medicine against COVID-19 to be recommended for authorization in the EU,” the agency says. Last month, the U.S. Food and Drug Administration granted an emergency use authorization for the drug.

Although larger trials on remdesivir are still ongoing, preliminary results showed that patients hospitalized with severe illness were discharged quicker from the hospital than those who didn’t get the drug. No beneficial effect was seen in patients with mild or moderate disease.

RELATED

ATHENS – While the New Democracy government is easing health restrictions for rabid anti-vaxxers, those fully vaccinated against COVID-19 may need a fourth shot in the autumn.

Top Stories

Columnists

A pregnant woman was driving in the HOV lane near Dallas.

General News

FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

Video

Greek-American Cornell Student Rescues Man on Subway Tracks in the Bronx

NEW YORK – Greek-American Cornell University senior Bryce Demopoulos rescued a man who had fallen on the subway tracks at the Third Avenue-138 Street station on the No.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. abc@xyz.com

You may unsubscribe at any time using the link in our newsletter.